查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球光学成像市场 - 2023-2030 年
市场调查报告书
商品编码
1319144

全球光学成像市场 - 2023-2030 年

Global Optical Imaging Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概述

2022 年，全球光学成像市场规模达到 16 亿美元，预计到 2030 年将达到 40 亿美元，实现利润丰厚的增长。预计在预测期内（2023-2030 年），全球光学成像市场将呈现 12.4% 的复合年增长率。

光学成像利用吸收和散射等光子特性来测量和感知器官和软组织的质量。尽管光学成像技术仍处于早期发展阶段，但与目前的成像方法相比，它具有多项技术优势。医生利用照片诊断和治疗各种疾病，科学家则利用照片开展各种研究项目。与使用电离辐射成像的核磁共振成像和 X 射线相比，光学成像已被证明更加安全和高效。

市场动态

肿瘤领域对无辐射设备的需求不断增长

对更安全、更准确的诊断仪器的渴望推动了癌症领域对无辐射光学成像技术的需求。这些方法具有实时成像、出色的分辨率以及从分子水平描述组织特征的能力等优点。

光学成像通过减少辐射照射和提供有关肿瘤生物学的重要信息，在改善癌症检测、诊断和治疗规划方面发挥着至关重要的作用。例如，2022 年 10 月，GenWorks 推出了无辐射设备 Braster Pro，这是一种易于使用的接触式乳腺癌筛查设备，旨在通过提供早期检测和减少辐射照射来彻底改变医院。

光学成像技术的进步是预测期内市场的主要驱动力之一

光学成像技术的进步是预测期内市场增长的主要驱动力之一。光学成像技术的发展大大提高了其在医学、生物学、材料科学等多个领域的能力和应用。

例如，2023 年 3 月，CytoVeris 和佛罗里达州中部 AdventHealth 合作开展了一项临床研究，通过在手术中使用人工智能驱动的成像设备来改善前列腺癌的治疗效果。该设备名为 MarginASSURE，旨在通过提供实时、准确的边缘评估，改善手术决策和患者预后。

全球光学成像市场熟练操作人员短缺

光学成像是一种先进的诊断工具，需要熟练的操作人员才能有效使用。然而，合格操作人员的短缺，尤其是在发展中国家，阻碍了光学成像在临床诊断中的应用。快速变化的技术环境要求医疗服务提供者掌握操作先进成像系统的必要技能。预计在预测期内，这种延迟采用将阻碍市场的增长。

COVID-19 影响分析

COVID-19 疫情增强了医生和其他医疗工作者保持社会距离的必要性。受 COVID-19 的影响，一些成像和诊断部门的光学成像病例量急剧下降。光学成像病例的减少对所有执业机构的短期和长期经济生存能力都有重大影响。

根据发表在《美国放射学会杂志》（JACR）上的一项研究，与2019年相比，在这次全球健康危机中，为期七周的总成像量减少了近28%，其中包括所有患者服务地点和成像方式类型。

俄乌战争影响分析

据估计，俄乌冲突对全球光学成像市场的影响不大，原因是该地区的发病率较低，而且没有主要的市场参与者。不过，在预测期内，设备进出口对全球光学成像市场增长的影响预计不大。

目 录

第 1 章：研究方法与范围

  • 研究方法
  • 报告的研究目标和范围

第2章：定义和概述

第 3 章：执行摘要

  • 按技术摘录
  • 按产品划分
  • 按治疗领域划分
  • 按应用摘录
  • 按最终用户分类
  • 按地区片段

第四章：动态

  • 影响因素
    • 驱动因素
      • 肿瘤领域对无辐射设备的需求不断增长
      • 光学成像技术的进步
    • 限制因素
      • 全球光学成像市场缺乏熟练的操作人员
    • 机会
      • 新兴技术
    • 影响分析

第 5 章：行业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析

第 6 章：COVID-19 分析

  • COVID-19 分析
    • COVID-19 之前的情况
    • COVID-19 期间的情景
    • COVID-19 后的情况
  • COVID-19 期间的定价动态
  • 供求关系
  • 大流行期间与市场相关的政府倡议
  • 制造商的战略倡议
  • 结论

第 7 章：按技术分类

  • 光学相干断层扫描（OCT）
  • 内窥镜
  • 光声成像
  • 弥散光学断层扫描 (DOT)
  • 拉曼光谱
  • 超分辨率显微镜
  • 其他

第 8 章：按产品分类

  • 成像系统
  • 照明系统
  • 软件
  • 镜头
  • 照相机

第 9 章：按治疗领域划分

  • 眼科
  • 肿瘤学
  • 神经内科
  • 心脏病学
  • 皮肤科
  • 其他

第 10 章：按应用分类

  • 病理成像
  • 术中成像
  • 其他

第 11 章：按最终用户

  • 医院/诊所
  • 诊断成像中心
  • 研究实验室
  • 其他

第十二章：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 意大利
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 亚太其他地区
  • 中东和非洲

第 13 章 ：竞争格局

  • 竞争格局
  • 市场定位/份额分析
  • 合併与收购分析

第14章：公司简介

  • Abbott Laboratories
    • 公司概况
    • 产品组合和说明
    • 财务概况
    • 主要发展
  • Carl-Zeiss AG
  • Canon Inc.
  • Danaher Corporation
  • Koninklijke Philips N.V.
  • PerkinElmer Inc.
  • Topcon Healthcare
  • Leica Microsystems
  • Visionix
  • Cylite Pty Ltd

第 15 章 ：附录

简介目录
Product Code: MD1201

Market Overview

The global optical imaging market reached US$ 1.6 billion in 2022 and is expected to witness lucrative growth by reaching up to US$ 4.0 billion by 2030. the global optical imaging market is expected to exhibit a CAGR of 12.4% during the forecast period (2023-2030).

Optical imaging employs photon characteristics such as absorption and scattering to measure and perceive the qualities of organs and soft tissues. Despite the fact that optical imaging technology is still in its early stages of development, it offers several technological benefits over current imaging methods. Doctors use photos to diagnose and cure various disorders, while scientists use them to conduct a variety of research projects. In comparison to MRI and X-ray, which employ ionising radiation for imaging, optical imaging has been shown to be significantly safer and more efficient.

Market Dynamics

Rising Demand For Radiation-Free Devices in Oncology

The desire for safer and more accurate diagnostic instruments drives the demand for radiation-free optical imaging techniques in cancer. These approaches have the benefit of real-time imaging, excellent resolution, and the ability to characterise tissues at the molecular level.

Optical imaging plays a critical role in improving cancer detection, diagnosis, and treatment planning by reducing radiation exposure and providing essential information about tumour biology. For instance, In Oct 2022, GenWorks introduced the Braster Pro, a radiation-free device, easy-to-use, contact-based breast cancer screening device, aiming to revolutionize hospitals by providing early detection and reducing radiation exposure.

Technological Advancements in Optical Imaging is one of the Key Significant Drivers in the Market during Forecast Period

Technological advancements in optical imaging is one of the key significant drivers that help the market to grow during the forecast period. Optical imaging technology developments have substantially improved its capabilities and use in a variety of sectors, including medicine, biology, materials science, and others.

For instance, In March 2023 CytoVeris and AdventHealth Central Florida have collaborated on a clinical study to improve prostate cancer outcomes by using AI-powered imaging devices during surgery. The device, called MarginASSURE, aims to enhance surgical decision-making and patient outcomes by providing real-time, accurate margin assessment.

Shortage of Skilled Operators in the Global Optical Imaging Market

Optical imaging is an advanced diagnostic tool that requires skilled operators for effective use. However, a shortage of qualified operators, especially in developing nations, hinders its use in clinical diagnostic applications. The rapidly changing technological landscape requires healthcare providers to acquire the necessary skills to operate advanced imaging systems. This delay in adoption is expected to hinder the market's growth during the forecast period.

COVID-19 Impact Analysis

The COVID-19 epidemic enhanced the necessity for doctors and other healthcare workers to maintain social distancing. As a result of COVID-19, several imaging and diagnostic departments have witnessed a rapid decline in optical imaging case volumes. The fall in optical imaging cases has major consequences for all practising settings' short- and long-term economic viability.

According to a study published in the Journal of the American College of Radiology (JACR), a nearly 28 per cent decrease in total imaging volume was observed during this global health crisis over a seven-week period when compared to 2019, and this included all patient service locations and imaging modality types.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine conflict is estimated to have a moderate impact on the global optical imaging market, owing to the low prevalence and absence of key market players in this region. however, the impact of the import and export of devices is expected to have little influence over the global optical imaging market growth over the forecast period.

Segment Analysis

The global optical imaging market is segmented based on infection type, drug type, end user and region.

The Optical Coherence Tomography (OCT) from the Technology Segment Accounted for Approximately 40.1 % of the Optical Imaging Share

The optical coherence tomography from the technology segment with around (40.1%) is expected to dominate during the forecast period. Non-invasive imaging tests include optical coherence tomography (OCT) and optical coherence tomography angiography (OCTA). They capture cross-section photographs of your retina using light waves.

OCT is a non-invasive medical imaging tool that is increasingly being used in the regular examination and therapy of patients with neuro-ophthalmic diseases. Its capacity to define the optic nerve head, peripapillary retinal nerve fibre layer, and cellular layers of the macula, including the ganglion cell layer, allows for both qualitative and quantitative evaluation of optic nerve pathology.

For instance, In Sep 2022 Kubota Vision announced a collaboration agreement with Joslin Diabetes Center for their Patient Based Ophthalmology Suite (PBOS) in-home optical coherence tomography (OCT) device. The collaboration aims to evaluate the effectiveness of home-based OCT in evaluating diabetic macular edema and monitoring patients at risk for losing vision. The agreement aims to improve the quality of care for patients with diabetic macular edema.

Geographical Analysis

North America Accounted for Approximately 38.7% of the Market Share

North America is estimated to hold about 38.7% of the total market share throughout the forecast period with enormous possibilities. For instance, According to a report published in NCBI by the Department of Neurology, it is estimated that 30 million people in India suffer from neurological disorders. The optical image market is expected to grow due to the large patient pool, healthcare technology adaptation, government initiatives, and favourable insurance policies. Key players are also setting up regional headquarters and manufacturing plants in emerging economies like Singapore, China, Korea, and India, resulting in a positive growth curve in the optical imaging market.

Competitive Landscape

The major global players in optical imaging include: Abbott Laboratories, Carl-Zeiss AG, Canon Inc, Danaher Corporation, Koninklijke Philips N.V, PerkinElmer Inc, Topcon Healthcare, Leica Microsystems, Visionix, Cylite Pty Ltd and others.

Why Purchase the Report?

  • To visualize the global optical imaging market segmentation based on technology, product, therapeutic area, application, end user and region. end user and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of optical imaging market level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping available as excel consisting of key products of all the major players.

The global optical imaging market report would provide approximately 53 tables, 54 figures and 195 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Technology
  • 3.2. Snippet by Product
  • 3.3. Snippet by Therapeutic Area
  • 3.4. Snippet by Application
  • 3.5. Snippet by End User
  • 3.6. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising demand for radiation-free devices in oncology
      • 4.1.1.2. Technological Advancements in Optical Imaging
    • 4.1.2. Restraints
      • 4.1.2.1. Shortage of skilled operators in the Global Optical Imaging Market
    • 4.1.3. Opportunity
      • 4.1.3.1. Emerging Technologies
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Technology

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 7.1.2. Market Attractiveness Index, By Technology
  • 7.2. Optical Coherence Tomography (OCT)*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Endoscopy
  • 7.4. Photoacoustic imaging
  • 7.5. Diffused optical tomography (DOT)
  • 7.6. Raman Spectroscopy
  • 7.7. Super-resolution microscopy
  • 7.8. Others

8. By Product

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 8.1.2. Market Attractiveness Index, By Product
  • 8.2. Imaging System *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Illumination System
  • 8.4. Software
  • 8.5. Lenses
  • 8.6. Camera

9. By Therapeutic Area

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapeutic Area
    • 9.1.2. Market Attractiveness Index, By Therapeutic Area
  • 9.2. Ophthalmology *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Oncology
  • 9.4. Neurology
  • 9.5. Cardiology
  • 9.6. Dermatology
  • 9.7. Others

10. By Application

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.1.2. Market Attractiveness Index, By Application
  • 10.2. Pathological Imaging *
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3. Intra-Operative Imaging
  • 10.4. Others

11. By End User

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 11.1.2. Market Attractiveness Index, By End User
  • 11.2. Hospitals/Clinics *
    • 11.2.1. Introduction
    • 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 11.3. Diagnostic Imaging Centres
  • 11.4. Research Laboratories
  • 11.5. Others

12. By Region

  • 12.1. Introduction
    • 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 12.1.2. Market Attractiveness Index, By Region
  • 12.2. North America
    • 12.2.1. Introduction
    • 12.2.2. Key Region-Specific Dynamics
    • 12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapeutic Area
    • 12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.2.8.1. U.S.
      • 12.2.8.2. Canada
      • 12.2.8.3. Mexico
  • 12.3. Europe
    • 12.3.1. Introduction
    • 12.3.2. Key Region-Specific Dynamics
    • 12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapeutic Area
    • 12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.3.8.1. Germany
      • 12.3.8.2. U.K.
      • 12.3.8.3. France
      • 12.3.8.4. Spain
      • 12.3.8.5. Italy
      • 12.3.8.6. Rest of Europe
  • 12.4. South America
    • 12.4.1. Introduction
    • 12.4.2. Key Region-Specific Dynamics
    • 12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapeutic Area
    • 12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.4.8.1. Brazil
      • 12.4.8.2. Argentina
      • 12.4.8.3. Rest of South America
  • 12.5. Asia-Pacific
    • 12.5.1. Introduction
    • 12.5.2. Key Region-Specific Dynamics
    • 12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapeutic Area
    • 12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 12.5.8.1. China
      • 12.5.8.2. India
      • 12.5.8.3. Japan
      • 12.5.8.4. Australia
      • 12.5.8.5. Rest of Asia-Pacific
  • 12.6. Middle East and Africa
    • 12.6.1. Introduction
    • 12.6.2. Key Region-Specific Dynamics
    • 12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technology
    • 12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Therapeutic Area
    • 12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

13. Competitive Landscape

  • 13.1. Competitive Scenario
  • 13.2. Market Positioning/Share Analysis
  • 13.3. Mergers and Acquisitions Analysis

14. Company Profiles

  • 14.1. Abbott Laboratories*
    • 14.1.1. Company Overview
    • 14.1.2. Product Portfolio and Description
    • 14.1.3. Financial Overview
    • 14.1.4. Key Developments
  • 14.2. Carl-Zeiss AG
  • 14.3. Canon Inc.
  • 14.4. Danaher Corporation
  • 14.5. Koninklijke Philips N.V.
  • 14.6. PerkinElmer Inc.
  • 14.7. Topcon Healthcare
  • 14.8. Leica Microsystems
  • 14.9. Visionix
  • 14.10. Cylite Pty Ltd

LIST NOT EXHAUSTIVE

15. Appendix

  • 15.1. About Us and Services
  • 15.2. Contact Us